Fredun Pharmaceuticals Ltd. | Small-cap | Healthcare
₹811.10
-1.33%
| Fredun Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 4.5B
Gross Profit 1.0B 23.05%
Operating Income 474.2M 10.50%
Net Income 197.4M 4.37%

Balance Sheet Metrics

Total Assets 4.9B
Total Liabilities 3.5B
Shareholders Equity 1.4B
Debt to Equity 2.45

Cash Flow Metrics

Operating Cash Flow -1.1B
Free Cash Flow -351.7M

Revenue & Profitability Trend

Fredun Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 4.5B 3.5B 2.7B 2.2B 1.3B
Cost of Goods Sold 3.5B 2.7B 2.2B 1.8B 1.1B
Gross Profit 1.0B 716.4M 560.7M 374.8M 244.6M
Operating Expenses 315.4M 185.7M 141.9M 123.5M 71.2M
Operating Income 474.2M 342.0M 249.9M 128.6M 75.1M
Pre-tax Income 274.9M 214.5M 175.1M 86.0M 32.1M
Income Tax 77.5M 58.3M 67.0M 22.6M 11.9M
Net Income 197.4M 156.2M 108.1M 63.4M 20.1M
EPS (Diluted) - ₹33.32 ₹22.93 ₹15.26 ₹5.05

Income Statement Trend

Fredun Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 4.3B 2.6B 2.2B 1.5B 1.3B
Non-Current Assets 594.6M 504.0M 410.7M 343.4M 315.4M
Total Assets 4.9B 3.1B 2.6B 1.9B 1.6B
Liabilities
Current Liabilities 3.2B 1.7B 1.4B 737.5M 864.6M
Non-Current Liabilities 248.5M 193.0M 212.5M 451.8M 320.9M
Total Liabilities 3.5B 1.9B 1.6B 1.2B 1.2B
Equity
Total Shareholders Equity 1.4B 1.2B 963.8M 680.6M 430.7M

Balance Sheet Composition

Fredun Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 200.3M 156.2M 107.6M 63.1M 20.1M
Operating Cash Flow -1.1B -189.3M -321.4M 49.9M -145.4M
Investing Activities
Capital Expenditures -59.9M -76.4M -94.0M -41.4M -13.9M
Investing Cash Flow -63.5M -76.4M -94.0M -41.4M -13.9M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 640.2M 222.8M 275.7M -7.9M -141.7M
Free Cash Flow -351.7M -80.8M -239.0M -66.7M -12.2M

Cash Flow Trend

Fredun Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.29
Price to Book 2.55
Price to Sales 0.85

Profitability Ratios

Profit Margin 4.33%
Operating Margin 9.21%
Return on Equity 15.02%
Return on Assets 7.84%

Financial Health

Current Ratio 1.33
Debt to Equity 118.22
Beta 0.85

Per Share Data

EPS (TTM) ₹44.80
Book Value per Share ₹321.10
Revenue per Share ₹1,036.23

Financial data is updated regularly. All figures are in the company's reporting currency.